Most Recent Annual Report
2019 Annual Report and Form 10K
Puma Biotechnology Inc has reached its limit for free report views.
You can request a free hardcopy of this report mailed to you by clicking the button below.
Puma Biotechnology Inc
Order Free Hardcopy
About Puma Biotechnology Inc
51-200 Employees
Based in Los Angeles, California
Puma Biotechnology, Inc., a development stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of products for the treatment of various forms of cancer. Its drug candidates include PB272 (neratinib (oral)) for the treatment of advanced breast cancer patients, non-small cell lung cancer patients, and patients with HER2 mutation-positive solid tumors; and PB272 (neratinib (intravenous)) for the treatment of advanced cancer patients.
- Ticker:
- PBYI
- Exchange:
- NYSE (See More NYSE Companies)
- Industry:
- Biotechnology (See More Biotechnology Companies)
- Sector:
- Healthcare (See More Healthcare Companies)